Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2005;58:328-330; doi:10.1136/jcp.2004.017640
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2005;58:328-330
© 2005 BMJ Publishing Group Ltd & Association of Clinical Pathologists

SHORT REPORT

An immunohistochemical analysis to evaluate an inverse correlation between Runx2/Cbfa1 and NF{kappa}B in human osteosarcoma

V B Andela1, F Siddiqui2, A Groman3 and R N Rosier2

1 The James P Wilmot Cancer Center, University of Rochester Medical Center, 601 Elmwood Avenue Box 665, Rochester, NY, 14642, USA
2 The Department of Orthopaedics, Center for Musculoskeletal Research, University of Rochester Medical Center
3 The Department of Biostatistics, University of Rochester Medical Center

Correspondence to:
Correspondence to:
Dr V B Andela
University of Rochester Medical Center, 601 Elmwood Avenue Box 665, Rochester, NY, 14642, USA; v_andela{at}yahoo.com

ABSTRACT

Background: Dominant negative inhibition of nuclear factor {kappa}B (NF{kappa}B) signalling activity in a human osteosarcoma cell line (Saos2) results in malignant reversion and the induction of the osteoblast differentiating transcription factor, Runx2/Cbfa1. This observation suggests that there is an inverse relation between a transcription factor associated with malignant progression and chemoresistance (NF{kappa}B) and an osteoblast differentiating transcription factor (Runx2/Cbfa1).

Aims: To assess and correlate Runx2/Cbfa1 and NF{kappa}B (p65) immunoreactivity in human osteosarcoma.

Methods: Runx2/Cbfa1 and NF{kappa}B (p65) immunoreactivity was assessed on 11 paraffin wax embedded archival specimens of human primary osteosarcoma by standard immunohistochemical methods and scored on a scale of 0–3. A Pearson correlation analysis between Runx2/Cbfa1 and NF{kappa}B (p65) scores was established.

Results: Runx2/Cbfa1 was expressed constitutively in all pathology specimens of human osteosarcoma. Of note, a chondroblastic osteosarcoma showed the highest Runx2/Cbfa1 immunoreactivity. A Pearson correlation did not support an inverse correlation between Runx2/Cbfa1 and NF{kappa}B (p65) scores (r = 0.57) in human osteosarcoma.

Conclusion: Runx2/Cbfa1 immunoreactivity does not inversely correlate with NF{kappa}B immunoreactivity, and thus cannot serve as an indirect measure of NF{kappa}B activity or an independent predictive or prognostic indicator.

Abbreviations: NF{kappa}B, nuclear factor {kappa}B; Rb, retinoblastoma protein

Keywords: differentiation; nuclear factor {kappa}B; osteosarcoma; Runx2/Cbfa1; transformation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs